This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Novartis Ag, Glaxosmithkline LLC. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Francisco Henriquez: Innovator in Pharmaceutical Compositions
Introduction
Francisco Henriquez is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on novel pharmaceutical compositions that have the potential to impact therapeutic practices.
Latest Patents
Henriquez's latest patents include innovative pharmaceutical compositions that contain N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate. These patents detail methods of using the compositions in therapy and processes for preparing the same. His work in this area showcases his commitment to advancing medical science through innovative solutions.
Career Highlights
Throughout his career, Francisco Henriquez has worked with prominent companies in the pharmaceutical industry, including Novartis AG and GlaxoSmithKline LLC. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
Henriquez has collaborated with esteemed colleagues such as Lihong Wang and Douglas J. DeMarini. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Francisco Henriquez stands out as a dedicated inventor in the pharmaceutical field, with a focus on innovative compositions that hold promise for therapeutic applications. His contributions and collaborations reflect his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

